Section Arrow
Quote
FBIOP.NASDAQ
- Fortress Biotech
Quotes are at least 15-min delayed:2026/01/07 16:04 EST
After Hours
Last
 9.85
+0.03 (+0.31%)
Bid
8.46
Ask
10.5
High 9.85 
Low 9.85 
Volume 748 
Regular Hours (Closed)
Last
 9.82
-0.66 (-6.30%)
Day High 
10.6999 
Prev. Close
10.48 
1-M High
10.84 
Volume 
58.52K 
Bid
8.46
Ask
10.5
Day Low
9.74 
Open
10.49 
1-M Low
7.2095 
Market Cap 
35.92M 
Currency 美元 
P/E -- 
%Yield 1.99 
10-SMA 9.64 
20-SMA 9.06 
50-SMA 7.74 
52-W High 10.3 
52-W Low 4.72 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
--/--
Enterprise Value
108.63M
Balance Sheet
Book Value Per Share
N/A
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
57.68M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1316+0.0266+25.33%-- 
After Hours 0.1321 +0.0065 +5.18%
ERASErasca5.425+1.795+49.45%-- 
After Hours 4.49 -0.68 -13.15%
RXRXRecursion Pharmaceuticals4.885+0.335+7.36%-- 
After Hours 4.86 +0.01 +0.21%
VTYXVentyx Biosciences13.73+3.68+36.62%-- 
After Hours 13.73 0 0.00%
GLUEMonte Rosa Therapeutics23.3816+7.3716+46.04%54.09PE
After Hours 22.86 -0.42 -1.80%
Industry overview quotes are at least 15 minutes delayed
Business Description
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq,Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.